Electrophoretic Mobility Shift Assay

"Electrophoretic Mobility Shift Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An electrophoretic technique for assaying the binding of one compound to another. Typically one compound is labeled to follow its mobility during electrophoresis. If the labeled compound is bound by the other compound, then the mobility of the labeled compound through the electrophoretic medium will be retarded.

Descriptor ID	D024202
MeSH Number(s)	E05.196.401.500
Concept/Terms	Electrophoretic Mobility Shift Assay Electrophoretic Mobility Shift Assay EMSA Electrophoretic Technique EMSA Electrophoretic Techniques Electrophoretic Technique, EMSA Electrophoretic Techniques, EMSA Technique, EMSA Electrophoretic Techniques, EMSA Electrophoretic Band Shift Mobility Assay Mobility Shift Assay Assay, Mobility Shift Assays, Mobility Shift Mobility Shift Assays Bandshift Mobility Assay Assay, Bandshift Mobility Assays, Bandshift Mobility Bandshift Mobility Assays Mobility Assay, Bandshift Mobility Assays, Bandshift Supershift Mobility Assay Supershift Mobility Assay Assay, Supershift Mobility Assays, Supershift Mobility Mobility Assay, Supershift Mobility Assays, Supershift Supershift Mobility Assays Gel Shift Analysis Gel Shift Analysis Analyses, Gel Shift Analysis, Gel Shift Gel Shift Analyses Gelshift Analysis Gel Retardation Assay Assay, Gel Retardation Assays, Gel Retardation Gel Retardation Assays

Below are MeSH descriptors whose meaning is more general than "Electrophoretic Mobility Shift Assay".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Chemistry Techniques, Analytical [E05.196]
Electrophoresis [E05.196.401]
Electrophoretic Mobility Shift Assay [E05.196.401.500]

Below are MeSH descriptors whose meaning is related to "Electrophoretic Mobility Shift Assay".

Below are MeSH descriptors whose meaning is more specific than "Electrophoretic Mobility Shift Assay".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Electrophoretic Mobility Shift Assay" by people in this website by year, and whether "Electrophoretic Mobility Shift Assay" was a major or minor topic of these publications.

Bar chart showing 36 publications over 12 distinct years, with a maximum of 5 publications in 2002 and 2003

To see the data from this visualization as text, click here.

Year	Minor Topic	Total
2002	5	5
2003	5	5
2004	2	2
2005	3	3
2006	3	3
2007	3	3
2008	4	4
2009	4	4
2011	2	2
2012	3	3
2013	1	1
2015	1	1

Below are the most recent publications written about "Electrophoretic Mobility Shift Assay" by people in Profiles.

Chandramouly G, McDevitt S, Sullivan K, Kent T, Luz A, Glickman JF, Andrake M, Skorski T, Pomerantz RT. Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers. Chem Biol. 2015 Nov 19; 22(11):1491-1504.

View in: PubMed
Goodson KA, Wang Z, Haeusler AR, Kahn JD, English DS. LacI-DNA-IPTG loops: equilibria among conformations by single-molecule FRET. J Phys Chem B. 2013 Apr 25; 117(16):4713-22.

View in: PubMed
Rao S, Lee SY, Gutierrez A, Perrigoue J, Thapa RJ, Tu Z, Jeffers JR, Rhodes M, Anderson S, Oravecz T, Hunger SP, Timakhov RA, Zhang R, Balachandran S, Zambetti GP, Testa JR, Look AT, Wiest DL. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood. 2012 Nov 01; 120(18):3764-73.

View in: PubMed
Pierrat MJ, Marsaud V, Mauviel A, Javelaud D. Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-?. J Biol Chem. 2012 May 25; 287(22):17996-8004.

View in: PubMed
Tripathi SK, Yadav S, Gupta KC, Kumar P. Synthesis and evaluation of N-(2,3-dihydroxypropyl)-PEIs as efficient vectors for nucleic acids. Mol Biosyst. 2012 Apr; 8(5):1426-34.

View in: PubMed
Doyle GA, Wang MJ, Chou AD, Oleynick JU, Arnold SE, Buono RJ, Ferraro TN, Berrettini WH. In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression. PLoS One. 2011; 6(8):e23373.

View in: PubMed
Palomer X, Álvarez-Guardia D, Davidson MM, Chan TO, Feldman AM, Vázquez-Carrera M. The interplay between NF-kappaB and E2F1 coordinately regulates inflammation and metabolism in human cardiac cells. PLoS One. 2011; 6(5):e19724.

View in: PubMed
Nagy ZS, LeBaron MJ, Ross JA, Mitra A, Rui H, Kirken RA. STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells. Mol Cancer. 2009; 8:67.

View in: PubMed
Yang Y, Gozen O, Watkins A, Lorenzini I, Lepore A, Gao Y, Vidensky S, Brennan J, Poulsen D, Won Park J, Li Jeon N, Robinson MB, Rothstein JD. Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1. Neuron. 2009 Mar 26; 61(6):880-94.

View in: PubMed
Yang M, He RL, Benovic JL, Ye RD. beta-Arrestin1 interacts with the G-protein subunits beta1gamma2 and promotes beta1gamma2-dependent Akt signalling for NF-kappaB activation. Biochem J. 2009 Jan 1; 417(1):287-96.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement